Sandler Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-40,731
Closed -$11M 122
2021
Q4
$11M Sell
40,731
-34,999
-46% -$8.66M 0.95% 45
2021
Q3
$18.3M Buy
75,730
+39,727
+110% +$10M 1.62% 16
2021
Q2
$8.53M Sell
36,003
-33,837
-48% -$7.71M 0.67% 56
2021
Q1
$15.3M Buy
69,840
+34,338
+97% +$6.89M 1.31% 23
2020
Q4
$6.21M Buy
+35,502
New +$6.13M 0.73% 55
2018
Q2
Sell
-44,232
Closed -$6.15M 120
2018
Q1
$6.15M Buy
+44,232
New +$6.5M 0.75% 59
2016
Q3
Sell
-111,674
Closed -$12.5M 123
2016
Q2
$12.5M Buy
+111,674
New +$12M 1.65% 19
2015
Q4
Sell
-8,841
Closed -$824K 167
2015
Q3
$824K Sell
8,841
-197,199
-96% -$20.4M 0.1% 121
2015
Q2
$21.5M Buy
206,040
+16,320
+9% +$1.7M 1.91% 6
2015
Q1
$20.6M Buy
+189,720
New +$19.5M 1.27% 10
2014
Q3
Sell
-179,954
Closed -$15.8M 210
2014
Q2
$15.8M Buy
+179,954
New +$15.6M 0.66% 53

Other funds holding LH

Sandler Capital Management's LH Position: Q1 2022 in Review

Sandler Capital Management sold out of Labcorp (LH) in Q1 2022, closing a stake of 40,731 shares — an estimated $11M sold.

Sandler Capital Management first reported a position in LH in Q2 2014 and held it in 11 quarters. The position peaked at $21.5M in Q2 2015. 1,033 funds tracked by Wall St. Rank hold LH as of Q1 2022.

  • Sandler Capital Management reported no remaining Labcorp position as of Q1 2022 after selling out during the quarter.
  • Sandler Capital Management sold 40,731 Labcorp shares in Q1 2022, an estimated $11M.
  • Sandler Capital Management first reported a position in Labcorp in Q2 2014 and held it in 11 quarters.
  • Sandler Capital Management's Labcorp position peaked at $21.5M in Q2 2015.
  • 1,033 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on Sandler Capital Management's 13F filing for Q1 2022, filed 16 May 2022.